<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">



Cellular and molecular interactions involved in neuroinflammation

Potential targets for improved patient outcome

The most common form of stroke is acute ischemic stroke (approximately 85% of cases), which is caused by either atherothrombosis in a major cervical or intracranial artery or an embolism that travels from the heart. The resulting occlusion causes a sudden deficiency of oxygen and glucose in the brain region normally serviced by the blocked artery. Stroke suffers experience a range of neurological deficits including partial paralysis, impaired memory, loss of speech, and/or decreased cognition.


This eBook is an overview of the cellular and molecular interactions involved in neuroinflammation following acute ischemic stroke:
  • Overview of preclinical models and their utility
  • Current therapies and therapeutic windows
  • Cell types involved in post-stroke inflammation
The complex interplay between resident and invading cells and their bioactive effector signaling molecules that initially damage and later protect and repair brain tissue offers many opportunities for pharmacological intervention.